1 |
Balassoulis G, Sichletidis L, Spyratos D, et al. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. Am J Clin Oncol 2008;31:384-9.
DOI
|
2 |
Yoshida K, Sugiura T, Takifuji N, et al. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Lung Cancer 2007;58:362-8.
DOI
|
3 |
Rafiei R, Yazdani B, Ranjbar SM, et al. Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin. Adv Biomed Res 2014;3:149.
DOI
|
4 |
Miller Q, Meschter C, Neumaster T, et al. Comparison of pleurodesis by erythromycin, talc, doxycycline, and diazepam in a rabbit model. J Surg Educ 2007;64:41-5.
DOI
|
5 |
Kuzdzal J, Sladek K, Wasowski D, et al. Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med Sci Monit 2003;9:PI54-9.
|
6 |
Bilaceroglu S, Guo Y, Hawthorne ML, et al. Oral forms of tetracycline and doxycycline are effective in producing pleurodesis. Chest 2005;128:3750-6.
DOI
|
7 |
Baumann MH. Treatment of spontaneous pneumothorax. Curr Opin Pulm Med 2000;6:275-80.
DOI
|
8 |
Salzer G. The local treatment of malignant pleural exudations with Iscador (a drug obtained from Misteltoe): preliminary report (author's transl). Osterr Z Onkol 1977;4:13-4.
|
9 |
Stumpf C, Bussing A. Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anticancer Drugs 1997;8 Suppl 1:S23-6.
|
10 |
Cho JS, Na KJ, Lee Y, et al. Chemical pleurodesis using mistletoe extraction (ABNOVAviscum Injection) for malignant pleural effusion. Ann Thorac Cardiovasc Surg 2016;22:20-6.
DOI
|
11 |
Farrar JT, Troxel AB, Stott C, Duncombe P, Jensen MP. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008;30:974-85.
DOI
|
12 |
Gaafar R, Abdel Rahman AR, Aboulkasem F, El Bastawisy A. Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin. Ecancermedicalscience 2014;8:424.
|
13 |
Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004;(1):CD002916.
|
14 |
Froudarakis ME, Klimathianaki M, Pougounias M. Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006;129:356-61.
DOI
|
15 |
Chen JS, Hsu HH, Kuo SW, et al. Effects of additional minocycline pleurodesis after thoracoscopic procedures for primary spontaneous pneumothorax. Chest 2004;125:50-5.
DOI
|
16 |
Herrington JD, Gora-Harper ML, Salley RK. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996;16:280-5.
|
17 |
Caglayan B, Torun E, Turan D, et al. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol 2008;15:2594-9.
DOI
|
18 |
Salomaa ER, Pulkki K, Helenius H. Pleurodesis with doxycycline or Corynebacterium parvum in malignant pleural effusion. Acta Oncol 1995;34:117-21.
DOI
|
19 |
Light RW, O'Hara VS, Moritz TE, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax: results of a department of veterans affairs cooperative study. JAMA 1990;264:2224-30.
DOI
|
20 |
Eriksson K, Wikstrom L, Arestedt K, Fridlund B, Brostrom A. Numeric rating scale: patients' perceptions of its use in postoperative pain assessments. Appl Nurs Res 2014;27:41-6.
DOI
|